Best Zaltrap (Aflibercept) Medicine in India

Zaltrap is a vascular endothelial growth factor (VEGF) inhibitor that blocks proteins responsible for tumor growth by preventing the formation of new blood vessels.

Doctors prescribe Zaltrap for adults with metastatic colorectal cancer who have previously been treated with an oxaliplatin-based chemotherapy regimen.

Zaltrap is given as an intravenous (IV) infusion by a healthcare professional, usually once every two weeks.

Common side effects of Zaltrap include fatigue, diarrhea, high blood pressure, decreased appetite, mouth sores, and nosebleeds.

Yes, Zaltrap may cause severe bleeding, gastrointestinal perforation, compromised wound healing, and high blood pressure. Contact your doctor if serious symptoms appear.

Zaltrap is taken as part of a chemotherapy regimen, and the duration is determined by the doctor based on treatment response and tolerance.

It is best to avoid alcohol while taking Zaltrap, as it may worsen side effects like liver toxicity and increased blood pressure.

No, Zaltrap may harm an unborn baby. Women should use effective contraception while undergoing treatment.

Yes, Zaltrap may interact with other drugs, including blood thinners and certain pain relievers. Inform your doctor of all medications you are taking.

Since Zaltrap is administered in a healthcare setting, a missed dose should be rescheduled as soon as possible by your doctor.

Zaltrap is given as an IV infusion, so food intake does not affect its administration.

Avoid surgery or dental procedures during treatment, monitor blood pressure regularly, and watch for signs of bleeding or infection.

Zaltrap should be stored in a healthcare facility at controlled temperatures and prepared by professionals before administration.

Zaltrap is available by prescription and is administered in hospitals or infusion centers. Consult your doctor for treatment options. Pharma Five assists in its procurement.